TP53 and prostate carcinoma: Since NF-κB pathway plays a vital role in prostate cancer cell survival, proliferation and resistance to chemotherapy, our findings suggest that this signaling pathway and activation of p53 represents key molecular targets for anticancer strategies, and that BA exemplifies a novel anticancer agent.